Skip to main content
. 2021 Apr 19;44(6):1393–1401. doi: 10.2337/dc20-2607

Table 2.

Subgroup analysis

Variable n of patients Follow-up duration, person-years Unadjusted Adjusted
Total AF HR (95% CI) P* Model 1 Model 2
HR (95% CI) P* HR (95% CI) P*
Sex group 0.728 0.261 0.350
 Male
  Constant drinkers 10,211 255 41,499 1 (reference) 1 (reference) 1 (reference)
  Abstainers 9,439 222 38,361 0.94 (0.79–1.13) 0.83 (0.69–0.99) 0.80 (0.67–0.96)
  Nondrinkers 30,073 930 118,248 1.28 (1.12–1.47) 0.83 (0.71–0.95) 0.80 (0.69–0.92)
 Female
  Constant drinkers 283 5 1,091 1 (reference) 1 (reference) 1 (reference)
  Abstainers 876 16 3,499 1.00 (0.37–2.72) 0.90 (0.33–2.46) 0.86 (0.31–2.34)
  Nondrinkers 72,596 1,630 289,418 1.23 (0.51–2.95) 0.69 (0.29–1.68) 0.66 (0.27–1.61)
Age group, years 0.429 0.329 0.267
 <65
  Constant drinkers 8,584 156 35,200 1 (reference) 1 (reference) 1 (reference)
  Abstainers 7,705 135 31,745 0.96 (0.76–1.21) 0.97 (0.77–1.22) 0.92 (0.73–1.16)
  Nondrinkers 52,255 684 212,466 0.73 (0.61–0.86) 0.80 (0.66–0.98) 0.75 (0.61–0.92)
 ≥65
  Constant drinkers 1,910 104 7,390 1 (reference) 1 (reference) 1 (reference)
  Abstainers 2,610 103 10,115 0.72 (0.55–0.95) 0.71 (0.54–0.93) 0.69 (0.52–0.91)
  Nondrinkers 50,414 1,876 195,200 0.68 (0.56–0.83) 0.82 (0.66–1.00) 0.79 (0.64–0.97)
CHA2DS-VASc points 0.552 0.142 0.144
 < 3
  Constant drinkers 8,747 180 35,709 1 (reference) 1 (reference) 1 (reference)
  Abstainers 7,890 137 32,390 0.84 (0.67–1.05) 0.81 (0.65–1.01) 0.78 (0.63–0.98)
  Nondrinkers 43,704 600 176,686 0.68 (0.57–0.80) 0.74 (0.61–0.88) 0.71 (0.59–0.86)
 ≥3
  Constant drinkers 1,747 80 6,881 1 (reference) 1 (reference) 1 (reference)
  Abstainers 2,425 101 9,471 0.92 (0.68–1.20) 0.91 (0.68–1.22) 0.87 (0.65–1.17)
  Nondrinkers 58,965 1,960 230,980 0.73 (0.58–0.91) 0.95 (0.75–1.20) 0.90 (0.71–1.14)
Insulin use 0.547 0.605 0.639
 Nonuser
  Constant drinkers 9,346 228 38,077 1 (reference) 1 (reference) 1 (reference)
  Abstainers 8,341 175 34,184 0.85 (0.70–1.04) 0.77 (0.63–0.94) 0.77 (0.63–0.94)
  Nondrinkers 88,428 2,085 353,409 0.99 (0.86–1.13) 0.78 (0.67–0.91) 0.77 (0.66–0.89)
 User
  Constant drinkers 1,148 32 4,513 1 (reference)  1 (reference) 1 (reference)
  Abstainers 1,974 63 7,676 1.16 (0.76–1.77) 1.05 (0.69–1.62) 1.03 (0.67–1.58)
  Nondrinkers 14,241 475 54,257 1.23 (0.86–1.76) 0.98 (0.67–1.43) 0.95 (0.65–1.39)
Smoking status <0.001 0.213 0.222
 Nonsmoker
  Constant drinkers 1,799 60 7,336 1 (reference) 1 (reference) 1 (reference)
  Abstainers 3,115 80 12,598 0.78 (0.56–1.08) 0.77 (0.55–1.07) 0.73 (0.52–1.02)
  Nondrinkers 82,964 1,975 330,168 0.73 (0.57–0.95) 0.70 (0.53–0.92) 0.66 (0.51–0.87)
 Former
  Constant drinkers 3,798 90 15,375 1 (reference) 1 (reference) 1 (reference)
  Abstainers 3,586 91 14,559 1.07 (0.80–1.43) 0.95 (0.71–1.27) 0.92 (0.68–1.23)
  Nondrinkers 11,644 396 45,237 1.50 (1.19–1.88) 1.02 (0.80–1.29) 0.99 (0.78–1.26)
 Current
  Constant drinkers 4,897 110 19,880 1 (reference) 1 (reference) 1 (reference)
  Abstainers 3,614 67 14,703 0.82 (0.61–1.12) 0.76 (0.56–1.03) 0.75 (0.56–1.02)
  Nondrinkers 8,061 189 32,261 1.06 (0.84–1.34) 0.73 (0.57–0.94) 0.73 (0.57– 0.95)
BMI, kg/m2 0.191 0.104 0.073
 <25
  Constant drinkers 4,612 129 18,601 1 (reference) 1 (reference) 1 (reference)
  Abstainers 5,017 110 20,217 0.79 (0.61–1.01) 0.71 (0.55–0.91) 0.68 (0.53–0.88)
  Nondrinkers 53,635 1,370 212,530 0.93 (0.78–1.12) 0.81 (0.67–0.99) 0.79 (0.65–0.96)
 ≥25
  Constant drinkers 5,882 131 23,989 1 (reference) 1 (reference) 1 (reference)
  Abstainers 5,298 128 21,643 1.08 (0.85–1.38) 0.99 (0.77–1.26) 0.96 (0.75–1.23)
  Nondrinkers 49,034 1,190 195,136 1.12 (0.93–1.34) 0.83 (0.68–1.02) 0.80 (0.65–0.99)
*

P for interaction.

Model 1: adjusted for age and sex.

Model 2: adjusted for age, sex, BMI, smoking status, regular physical activity, low income, CHA2DS2-VASc score, hypertension, dyslipidemia, chronic heart failure, peripheral arterial disease, stroke/transient ischemic attack, thromboembolism, use of insulin, and number of oral hypoglycemic agents.